Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.2 - $0.33 $131 - $216
-656 Reduced 0.23%
279,456 $61,000
Q2 2022

Aug 12, 2022

BUY
$0.45 - $0.8 $2,562 - $4,555
5,694 Added 2.07%
280,112 $182,000
Q1 2022

May 13, 2022

SELL
$0.66 - $1.23 $2 - $4
-4 Reduced -0.0%
274,418 $225,000
Q4 2021

Feb 11, 2022

BUY
$1.09 - $2.55 $77,773 - $181,947
71,352 Added 35.14%
274,422 $312,000
Q3 2021

Nov 12, 2021

BUY
$2.06 - $5.34 $120,402 - $312,112
58,448 Added 40.41%
203,070 $507,000
Q2 2021

Aug 13, 2021

SELL
$2.88 - $5.64 $449,637 - $880,539
-156,124 Reduced 51.91%
144,622 $429,000
Q1 2021

May 12, 2021

BUY
$3.4 - $7.97 $121,502 - $284,815
35,736 Added 13.48%
300,746 $1.06 Million
Q4 2020

Feb 12, 2021

BUY
$4.11 - $7.51 $103,202 - $188,576
25,110 Added 10.47%
265,010 $1.26 Million
Q3 2020

Nov 13, 2020

BUY
$3.28 - $5.93 $2,870 - $5,188
875 Added 0.37%
239,900 $1.17 Million
Q2 2020

Aug 13, 2020

BUY
$3.18 - $15.54 $383,272 - $1.87 Million
120,526 Added 101.71%
239,025 $776,000
Q1 2020

May 14, 2020

BUY
$2.36 - $5.6 $23,090 - $54,790
9,784 Added 9.0%
118,499 $606,000
Q2 2019

Aug 14, 2019

BUY
$5.56 - $7.85 $148,830 - $210,128
26,768 Added 32.67%
108,715 $662,000
Q1 2019

May 14, 2019

BUY
$5.32 - $7.18 $19,306 - $26,056
3,629 Added 4.63%
81,947 $454,000
Q4 2018

Feb 13, 2019

BUY
$4.95 - $10.5 $130,972 - $277,819
26,459 Added 51.02%
78,318 $443,000
Q2 2018

Aug 14, 2018

BUY
$7.8 - $11.1 $18,649 - $26,540
2,391 Added 4.83%
51,859 $575,000
Q2 2017

Aug 14, 2017

BUY
N/A
49,468
49,468 $299,000

About CHEMBIO DIAGNOSTICS, INC.


  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.